Trial Profile
Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TITRATE
- Sponsors Novo Nordisk
- 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 05 Jun 2009 New trial record
- 01 Jun 2009 Primary endpoint proportion of patients achieving HbA1c levels less than 7% has been met according to results published in Diabetes, Obesity and Metabolism.